Back to today’s briefing

Story perspectives

RBC Raises Abbott Price Target Amid Insider Share Sale

4/21/2025

25 6

Summary

Story summary

Royal Bank of Canada has boosted Abbott Laboratories' price target from $140 to $145, signaling a promising 10.68% upside. This optimism is echoed by other firms, with a consensus target of $142.59. Meanwhile, insider EVP Lisa Earnhardt sold 91,167 shares, as institutional investors maintain a strong 75.18% stake in the global healthcare giant.

1 of 1

Story summary

Royal Bank of Canada has boosted Abbott Laboratories' price target from $140 to $145, signaling a promising 10.68% upside. This optimism is echoed by other firms, with a consensus target of $142.59. Meanwhile, insider EVP Lisa Earnhardt sold 91,167 shares, as institutional investors maintain a strong 75.18% stake in the global healthcare giant.